A controlled study was conducted to determine the efficiency of a topical ointment prepared from the stem extract of Morinda citrifolia against cutaneous leishmaniasis. Similarly, the in vitro antileishmanial activity of morindicone and morinthone isolated from the extract were investigated against Leishmania major. These compounds displayed good activity. Out of 40 patients, 50% showed an excellent response and 30% exhibited good improvement.
Leishmaniasis is a tropical disease caused by protozoa of the Leishmania genus [1a] . Despite many studies to find new antileishmanial drugs, first-line chemotherapy is still based on pentavalent antimonials developed more than 50 years ago. Alternative drugs, such as amphotericin B and pentamidine, also have unpleasant side-effects, and, therefore new drugs are still urgently needed [1b,2] . In Pakistan, cutaneous leishmaniasis is most prevalent in the northern mountain areas; a total of 1100 cases were reported in 2001-2002 during the biggest outbreak in the Larkana and Dadu Districts of Sindh province. Being a disease of tropical areas where the majority of the population belongs to the poor socioeconomic stratum, it cannot afford systemic therapy, which is quite expensive as compared with the local treatments [3] . Over 100 plants have been reported to be active against various forms of leishmanial parasites [4a] . Morinda citrifolia Linn (Rubiaceae), commonly called noni, has a long history as a medicinal plant. It has been reported to have a broad range of therapeutic properties, including antibacterial, antiviral, antifungal, antitumor, antihelminth, analgesic, hypotensive, anti-inflammatory, and immune enhancing effects. [4b]. In Pakistan, it is cultivated as an ornamental plant [5] [6] [7] . The present investigation evaluates the antileishmanial effects of the stem extract and of morindicone and morinthone isolated from the extract.
An ointment was prepared containing 1% of the dry methanol extract of leaves of M. citrifolia in petroleum jelly. Forty patients (30 male, 10 female) having cutaneous leishmaniasis sores and willing to apply the ointment were included in the study. The age distribution of these patients is shown in Table 1. All the patients were instructed to use the ointment on sores and ulcers three times a day after cleaning the lesions with soap and water. The patients were checked regularly, initially on every third day and then every week up to six weeks. All subjects were instructed to carry out their daily activity during the period of treatment without any hindrance. Out of 40 patients, an excellent response was observed in 20 (50%), a good response in 12 (30%) and no response in 8 (20%). In our study, no side effects were noted. Further comparative studies are recommended to evaluate the efficacy of this cheap treatment for cutaneous leishmaniasis.
Because of the results obtained in this preliminary study, a bioguided investigation of the extract was undertaken, which resulted in the isolation and characterization of morindicone (9-hydroxy-2-methoxy-4-methyl-3,10-anthracenedione; 1) and morinthone (4 methoxy-3-heptadecylxanthone; 2) ( Figure 1 ). Both compounds were evaluated for in vitro leishmanicidal activity to check whether or not they contribute to the reported results. The compounds showed substantial to mild leishmanicidal activity NPC Natural Product Communications 2012 Vol. 7
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against the promastigotes of L. major. Structural analysis of compound 2 showed that the presence of a long chain alkyl group at C-3, in the xanthone skeleton resulted in a decrease in activity, whereas in compound 1, the presence of a hydroxyl group at C-9 in the anthraquinone skeleton played a major role in the activity against leishmaniasis. Compound 2 had an IC 50 of 7.05 μg/mL as compared with the standard drug amphotericin B, IC 50 = 0.12 μg/mL, while the IC 50 value of compound 1 was 3.39 μg/mL. 
Extraction and isolation:
The stems of M. citrifolia (12 kg) were extracted with MeOH (×4) at room temperature. The solvent was removed under reduced pressure to yield 791 g of a thick syrupy extract. This was treated with H 2 O and EtOAc to give an EtOAc phase and the main aqueous phase. The EtOAc phase was dried (anhyd. Na 2 SO 4 ) and evaporated under vacuum. The residue (43.0 g) from the EtOAc extract was treated with n-hexane to give n-hexane soluble and insoluble fractions. The latter fraction was treated with Et 2 O to yield Et 2 O soluble and Et 2 O-insoluble fractions. The Et 2 O-insoluble fraction was divided into EtOAc-soluble and EtOAc insoluble fractions. The EtOAc-soluble fraction was subjected to vacuum liquid chromatography (VLC; silica gel PF 254 , n-hexane, n-hexane-EtOAc, CHCl 3 , CHCl 3 -MeOH, MeOH) to yield 9 fractions. Of these, Fr. 4 (2 g) was further separated by CC (silica gel PF 254 ) and eluted with CHCl 3 , CHCl 3 -MeOH, MeOH. Out of the fractions obtained from this column, Fr.12 (CHCl 3 -MeOH; 9.8:0.2 elute) and 20 (CHCl 3 -MeOH; 9.5:0.5 elute) yielded morindicone (1, 10 mg) [8c] and morinthone (2, 8 mg) [8c], respectively.
Antileishmanial assay: Leishmania major promastigotes were grown in bulk, early in modified NNN biphasic medium, using normal physiological saline. Then, the promastigotes were cultured with RPMI 1640 medium supplemented with 10% heat inactivated fetal bovine serum (FBS). The parasites (L. major), at log phase, were centrifuged at 2000 rpm for 10 mins and washed 3 times with saline at the same speed and time. Finally, the parasites were diluted with fresh culture medium to give a final density of 10 6 cells/mL. In a 96 well microtiter plate, 180 µL of the parasite culture (1×10 6 parasite/mL) was added to different wells in which 20 µL of the experimental compound was added in culture and serially diluted, so that minimum concentration of the compound was 1µg/mL. The negative control received medium with a parasite density of 1×10 6 parasite/mL. The positive control contained varying concentrations of standard antileishmanial compounds e.g., amphotericin B, pantamidine. The plate was incubated between 21-22 o C for 72 h. The culture was examined microscopically on an improved Neubauer chamber and IC 50 values of compounds possessing antileishmanial activity were estimated [8a,8b] .
